Cannabis research — studies & evidence

This topic brings together cannabis research articles and guidance on reading studies. Distinguish treatment effectiveness, health risks and findings about regulation, then assess how well each conclusion is supported.

Medical studies, population data and Swiss pilot trials answer different questions. This hub helps distinguish their aims, methods and limitations. For a specific claim, check the original source and when it was published.

Definition and context

Cannabis research encompasses pharmacological studies on cannabinoids, clinical trials on medical indications, and accompanying social science research into regulatory models.

The situation in Switzerland

With its approved pilot projects, Switzerland has established a study landscape for regulated distribution that has attracted attention across Europe. Findings from Zurich, Basel, and the SCRIPT consortium feed directly into the political debate regarding a potential change in system.

What this means in practice

For readers, this means there is a significant difference between reliable clinical data and marketing claims. Therapeutic or health claims for unauthorized products are not permitted in Switzerland—consequently, reputable providers do not make them.

Frequently asked questions

What do the Swiss pilot studies investigate?

Consumption patterns, health outcomes, and the market impact of a regulated distribution model compared to the status quo.

Is the efficacy of CBD scientifically proven?

Approved medicinal products exist for specific medical applications; however, robust evidence is lacking for general wellness claims.

Where can I find reliable sources?

FOPH publications, Addiction Switzerland, the EMCDDA, and peer-reviewed journals.

Background and development

Cannabis research addresses different questions. Laboratory experiments explore mechanisms; clinical trials assess specific treatments. Population studies and Swiss pilot trials examine topics such as consumption patterns and regulation. Their findings are not interchangeable.

Distinctions and misconceptions

A headline is not a robust conclusion. Check who participated, what the comparison was and how long follow-up lasted. A statistical difference can be small in everyday terms. Missing evidence about a risk does not establish that the risk is absent.

Decision guide for Switzerland

For each question, consult the original publication and, where possible, a recent systematic review. Separate benefits, adverse effects and uncertainty. Discuss treatment decisions with the professional responsible for your care: a general article cannot assess your individual circumstances.

Does one positive study prove an effect?

It may provide a signal. Study design, the comparison group, the size and precision of the effect, and other studies addressing the same question also matter.

Why examine funding and conflicts of interest?

They help identify potential bias. Funding alone does not invalidate a finding; methods, complete reporting and independent confirmation remain essential.

Explore this topic further

These guides explain the background and address practical questions in the Swiss context.

What does a cannabis study actually show?

Start with the question: treatment, health risk or regulation? Swiss pilot trials investigate controlled access to cannabis and its consequences. Their findings do not establish that cannabis is generally effective as a medicine.

Check the comparison group, participants and preparation studied. An observed association alone does not establish causation. A systematic review brings studies together; its strength also depends on their quality and the consistency of their results.

How large is the effect, how uncertain is the estimate, and were adverse effects measured? Do not automatically apply findings to other products or your own treatment. A calculator replaces neither a clinical study nor medical advice.

Our editorial principles

Current research

  • Swiss cannabis pilot trials: results — BAG / OFSP / UFSP / FOPH, Bundesamt für Gesundheit
  • How certain is the evidence? — Cochrane, Cochrane Handbook · Chapter 14
  • Interpreting study results — Cochrane, Cochrane Handbook · Chapter 15

Datasets on this topic